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Dear Editor,
E
vidence suggests a linkage between different 
environmental agents and the development of 
celiac  disease—an  immune-mediated  disorder—in 
those with a specific genetic predisposition (HLA-
DQ2, HLA-DQ8) who exposed to gluten—a major 
storage protein in wheat and other grains. Infections, 
particularly viral agents, have been hypothesized to 
induce  or  exacerbate  immune-mediated  disorders, 
possibly through a mechanism of molecular mimicry 
(1, 2). Others have suggested that treatment of chronic 
viral infections (i.e., with α-interferon) or vaccines 
administered for prevention may be further triggers 
the process (1). In celiac disease, a host of chronic 
immunologically-based liver disorders may occur (3). 
Some early studies noted a relatively high frequency 
of hypertransaminasemia in celiac disease that usually 
resolved with a gluten-free diet (4). Failure of raised 
transaminase values to fall with a gluten-free diet 
led to eventual detection of chronic infection with 
hepatitis B or C viruses leading to the hypothesis that 
infection with hepatitis B or C viruses may trigger or 
“unmask” the underlying celiac disease.
In the study conducted by Leonardi and Rosa 
(5), serological testing for celiac disease antibodies 
was performed in 60 patients with chronic hepatitis 
B carrier state or a prior, but recovered, hepatitis 
B  infection.  Some  of  the  carriers  were  treated 
for  12  months  with  α-interferon.  Selective  IgA 
deficiency was not present. In all 60 patients, IgA 
endomysial  antibodies  (EMA)—using  a  monkey 
esophagus  immunofluorescence  assay—and  IgA 
tissue transglutaminase antibodies (tTGA)—using a 
commercial ELISA assay—were negative.
In  summary,  a  linkage  between  hepatitis  B 
infection  and  serologically-defined  celiac  disease 
could not be established. Moreover, there was no 
evidence  that  α-interferon  could  activate  celiac 
disease. Although the investigators acknowledge the 
limited sample size of their hepatitis B cohort, the 
study still provides intriguing data. Future studies 
might  also  need  to  directly  examine  intestinal 
biopsies, not only for histological evidence of celiac 
disease, but for evidence of prior viral “footprints” (6), 
including identification of specific viral sequences.
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